Insider Selling: Evolv Technologies (NASDAQ:EVLV) Director Sells $468,032.10 in Stock

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Director Michael Ellenbogen sold 91,771 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $5.10, for a total value of $468,032.10. Following the sale, the director directly owned 2,083,961 shares in the company, valued at $10,628,201.10. The trade was a 4.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Michael Ellenbogen also recently made the following trade(s):

• On Tuesday, February 17th, Michael Ellenbogen sold 80,745 shares of Evolv Technologies stock. The shares were sold at an average price of $5.47, for a total value of $441,675.15.
• On Friday, January 16th, Michael Ellenbogen sold 80,745 shares of Evolv Technologies stock. The stock was sold at an average price of $6.20, for a total value of $500,619.00.

Evolv Technologies Stock Performance

NASDAQ EVLV opened at $5.75 on Thursday. The business’s 50 day moving average price is $5.96 and its 200-day moving average price is $6.90. Evolv Technologies Holdings, Inc. has a fifty-two week low of $2.64 and a fifty-two week high of $8.91. The company has a market cap of $1.00 billion, a P/E ratio of -27.38 and a beta of 1.89. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.20 and a current ratio of 1.27.

Evolv Technologies (NASDAQ:EVLV) last issued its quarterly earnings results on Tuesday, March 10th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.14. The company had revenue of $38.50 million during the quarter, compared to the consensus estimate of $36.44 million. Evolv Technologies had a negative return on equity of 31.47% and a negative net margin of 22.71%. Sell-side analysts predict that Evolv Technologies Holdings, Inc. will post -0.27 earnings per share for the current year.

Institutional Trading of Evolv Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of EVLV. IFC & Insurance Marketing Inc. bought a new stake in shares of Evolv Technologies during the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd grew its holdings in shares of Evolv Technologies by 471.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 6,806 shares of the company’s stock worth $49,000 after purchasing an additional 5,614 shares during the last quarter. State of Alaska Department of Revenue purchased a new position in Evolv Technologies in the 3rd quarter worth about $60,000. FNY Investment Advisers LLC increased its stake in Evolv Technologies by 48.3% in the 4th quarter. FNY Investment Advisers LLC now owns 8,897 shares of the company’s stock worth $63,000 after buying an additional 2,897 shares during the period. Finally, AlphaCore Capital LLC bought a new stake in Evolv Technologies during the 4th quarter valued at about $72,000. Hedge funds and other institutional investors own 66.65% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on EVLV shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Evolv Technologies in a research note on Thursday, January 22nd. Lake Street Capital increased their price objective on shares of Evolv Technologies from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Evolv Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $9.13.

More Evolv Technologies News

Here are the key news stories impacting Evolv Technologies this week:

• Positive Sentiment: Q4 top‑ and bottom‑line beat — Evolv reported revenue of $38.5M (+32% YoY) and adjusted EPS of $0.06, well ahead of analyst expectations, showing stronger demand and margin progress. Evolv Technologies Just Sent a Strong Signal on AI Security Demand
• Positive Sentiment: Raised FY2026 guidance and accelerating ARR — Management bumped 2026 revenue guidance to $172M–$178M (vs. consensus ~$165.8M) and expects ARR roughly $145M–$150M; ARR was $120.5M in Q4, up ~21% YoY — a meaningful recurring‑revenue tailwind. Evolv Technology raises 2026 revenue guidance to $178M while accelerating ARR growth
• Positive Sentiment: Investor visibility — Company scheduled an Investor Day for June 9, 2026, which gives management a forum to outline growth drivers (subscription mix, deployments, margin cadence) and could help sustain investor confidence. Evolv Technology to Host Investor Day on June 9, 2026
• Neutral Sentiment: Management commentary and details available — The full earnings release and transcript provide granular color on unit deployments, subscription mix (management expects ~50% of new units on pure subscription in 2026) and margin goals; useful for modeling but not new headline news. Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Analyst/previews and coverage — Several outlets posted previews and takeaways (Zacks, Benzinga) summarizing mixed operational detail — helpful context but not market‑moving by itself. EVLV Tops Q4 Earnings and Revenue Estimates (Zacks)
• Negative Sentiment: Insider selling — Director Michael Ellenbogen sold ~91,771 shares (filed this week), which some investors view as a negative signal on near‑term insider conviction (though he retains a large stake). Michael Ellenbogen Sells 91,771 Shares
• Negative Sentiment: Execution risks remain — Coverage notes the business can be lumpy, competition in AI‑enabled screening is growing, and Evolv must prove sustained profitability despite a one‑quarter beat and a forecast of first full year of positive adjusted EBITDA. MarketBeat analysis (risks and competitive landscape)

Evolv Technologies Company Profile

Evolv Technologies, Inc is a publicly traded American security technology company that develops and markets AI-driven weapons detection and screening solutions. The company’s proprietary platform combines advanced sensors, computer vision software and machine learning algorithms to identify potential threats—such as firearms and knives—while minimizing false positives and preserving high throughput. Evolv’s systems are designed to replace or supplement traditional metal detectors and manual bag checks in high-traffic venues.

The company’s flagship product, Evolv Express, integrates seamlessly into existing security checkpoints, allowing guests to pass through without stopping or emptying their pockets.